Anthem Biosciences Ltd.ANTHEM₹730.35 +28.13%

Shares of Anthem Biosciences Ltd. closed with a 28.13% gain on its first trading day, marking a robust debut on the Indian stock exchanges. The stock listed at ₹723.05 on the NSE, representing a 26.85% premium over its IPO price of ₹570. After touching an intraday high of ₹747, it settled at ₹730.35 by market close.

The upbeat listing follows strong subscription demand, with the crore IPO subscribed 63.85 times. 

Financial Snapshot

For FY25 (ending March 2025), Anthem Biosciences reported a 30% YoY growth in total income to ₹1,930 crore, with net profit rising 23% to ₹451 crore. EBITDA surged 33% year-on-year to ₹757 crore, reflecting operating efficiency improvements. The company’s revenue and profitability growth underline its robust operational performance in a competitive sector.

About Anthem Biosciences

Founded in 2006, Anthem Biosciences is one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), offering integrated drug discovery, development, and manufacturing services to biotech and pharma companies globally. The company’s expertise spans APIs, probiotics, enzymes, peptides, biosimilars, and vitamin analogues, serving over 550 clients across 44 countries, including the U.S., Europe, and Japan.

Its innovation-focused business model, diverse client base, and expanding global footprint position the company well to capitalize on the growing demand for outsourced drug development and manufacturing solutions.

Disclaimer

Investments in securities market are subject to market risks, read all the related documents carefully before investing. This is for informational purposes and should not be considered as recommendations.

Kindly refer to  https://share.market/ for more details.

PhonePe Wealth Broking Private Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000302639, Depository Participant of CDSL Depository with SEBI Regn. No.: IN-DP-696-2022, Research Analyst with SEBI Regn No: INH000013387, BSE RA Enlistment Number: 5887, and Mutual Fund distributor with AMFI Registration No: ARN- 187821. Member ID: BSE- 6756, NSE- 90226. 

Registration granted by SEBI, enlistment as Research Analyst, and Certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors

Registered office – 2, Floor 3, Wing A, Block A, Salarpuria Softzone, Service Road, Green Glen Layout, Bellandur, Bengaluru South, Bengaluru, Karnataka – 560103, INDIA.

CIN: U65990KA2021PTC146954.